- Home
- MTEN vs AIDX Comparison
MTEN vs AIDX Comparison
Compare MTEN & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTEN | AIDX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | China | United States |
| Employees | N/A | 14 |
| Industry | Building Products | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 6.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MTEN | AIDX |
|---|---|---|
| Price | $1.08 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 93.9K |
| Earning Date | 05-21-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.02 | $0.40 |
| 52 Week High | $15.49 | $14.09 |
Technical Indicators
Market Signals| Indicator | MTEN | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 34.45 |
| Support Level | $0.88 | $0.40 |
| Resistance Level | $1.27 | $0.57 |
| Average True Range (ATR) | 0.23 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 26.36 | 23.84 |
Price Performance
Historical ComparisonAbout MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup, including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.